Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Dendreon FDA Deadline Set For May 1
|
Luke Timmerman |
11/20/09 |
Seattle
|
|
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/12/09 |
Seattle
|
|
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus
|
Luke Timmerman |
11/10/09 |
Boston
|
|
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer
|
Luke Timmerman |
11/10/09 |
Boston
|
|
Dendreon Burns $28M in Q3
|
Luke Timmerman |
11/09/09 |
Seattle
|
|
Dendreon Files FDA Application, DxBox Reaches Turning Point, ISB to Do 100 Genomes, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/05/09 |
Seattle
|
|
Dendreon Files Provenge Application to FDA Ahead of Schedule, Now It’s Time to Wait
|
Luke Timmerman |
11/02/09 |
Seattle
|
|
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/01/09 |
Seattle
|
|
Lee Hood’s New Idea, Calypso Scores $50M, Novo’s Historic Mistake Pays Off for Seattle, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/25/09 |
Seattle
|
|
Dendreon to Turn in Provenge Application to FDA in Mid-November
|
Luke Timmerman |
09/24/09 |
Seattle
|
|
Five Big Questions For Dendreon’s Analyst Day
|
Luke Timmerman |
09/24/09 |
Seattle
|
|
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/13/09 |
Seattle
|
|
Dendreon Ends June with $287M Cash
|
Luke Timmerman |
08/11/09 |
Seattle
|
|
Dendreon Will Build Manufacturing Plant in Georgia
|
Eric Hal Schwartz |
08/10/09 |
Seattle
|
|
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 2
|
Luke Timmerman |
07/28/09 |
Seattle
|
|
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 1
|
Luke Timmerman |
07/27/09 |
Seattle
|
|
Dendreon Scouts for Next Manufacturing Plant, Probably Far From Salmon and Evergreens
|
Luke Timmerman |
07/22/09 |
Seattle
|
|
Dendreon May Open Atlanta Plant
|
Eric Hal Schwartz |
07/17/09 |
Seattle
|
|
Dendreon Tames Short Sellers, Transforms Itself into Old-School Buy-and-Hold Stock
|
Luke Timmerman |
06/30/09 |
Seattle
|
|
Dendreon, Resisting Urge to Sell, Eyes Opportunity to Be Seattle’s Next Immunex
|
Luke Timmerman |
06/10/09 |
Seattle
|
|
Dendreon’s Manufacturing Challenge, Archus Cuts Deep, Accelerator Company Launches & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/21/09 |
Seattle
|
|
Dendreon Drug Works, But Can It Manufacture Enough to Meet Demand?
|
Luke Timmerman |
05/20/09 |
Seattle
|
|
Dendreon and Cell Therapeutics Sell Stock, Microsoft Buys BigPark, Calistoga Raises $30M, & More Seattle-Area Deals News
|
Gregory T. Huang |
05/12/09 |
Seattle
|
|
Dendreon Raises $197M in Stock Offering
|
Luke Timmerman |
05/11/09 |
Seattle
|
|
Dendreon Sells Shares To Raise $200M For Provenge Manufacturing, Marketing
|
Luke Timmerman |
05/08/09 |
Seattle
|
|
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
Dendreon Plans to Raise Cash for Manufacturing, Marketing
|
Luke Timmerman |
05/06/09 |
Seattle
|
|
Dendreon Goes on Hiring Binge After Prostate Cancer Drug Boosts Survival
|
Luke Timmerman |
05/06/09 |
Seattle
|
|
Dendreon Execs Sell Shares
|
Luke Timmerman |
05/05/09 |
Seattle
|
|
Dendreon Drug Prolongs Life, ZymoGenetics Cuts Staff, Microsoft Tackles Biotech & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/30/09 |
Seattle
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
